Inventor · disambiguated record
Thomas Manley
Also filed as: MANLEY THOMAS · MANLEY THOMAS JOHN
2 granted patents·7 pending applications·2 citations·filing 2017–2023
44Inventor score
Top patents by PatentIndex Score
9 records- 0182US11202827B2Dosage and administration of non-fucosylated anti-CD40 antibodiesSEAGEN INC·Filed 2017·Granted Dec 21, 2021·2 cites·170 claims
- 0280US2024075135A1Dosage and administration of non-fucosylated anti-cd40 antibodiesSEAGEN INC·Filed 2023·Application pending·0 cites
- 0378US2023201343A1Dosage and administration of non-fucosylated anti-cd40 antibodiesSEAGEN INC·Filed 2022·Application pending·0 cites
- 0477US2022249662A1Dosage and administration of non-fucosylated anti-cd40 antibodiesSEAGEN INC·Filed 2022·Application pending·0 cites
- 0566US2024245753A1Methods of reducing side effects of anti-cd30 antibody drug conjugate therapySEAGEN INC·Filed 2023·Application pending·0 cites
- 0653US2022226439A1Methods of reducing side effects of anti-cd30 antibody drug conjugate therapySEAGEN INC·Filed 2018·Application pending·0 cites
- 0748US11795229B2Methods of reducing side effects of anti-CD30 antibody drug conjugate therapySEAGEN INC·Filed 2018·Granted Oct 24, 2023·0 cites·20 claims
- 0847US2020102399A1Methods of Treating Peripheral T Cell Lymphoma Using Anti-CD30 Antibody Drug Conjugate TherapySEATTLE GENETICS INC·Filed 2019·Application pending·0 cites
- 0942US2022347313A1Combination Anti-CD30 ADC, Anti-PD-1 and Chemotherapeutic for Treatment of Hematopoietic CancersSEAGEN INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Manley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →